William Kinney
Chief Tech/Sci/R&D Officer chez NEUROPATHIX, INC.
Profil
William A.
Kinney is the founder of Enterin, Inc. (founded in 2016) and Iteramed (founded in 2008), where he holds the titles of SVP-Research & Development and President, respectively.
Currently, he is the Director at Natural Product Discovery Institute, Chief Scientific Officer at Kannalife Sciences, Inc., and Chief Scientific Officer at Neuropathix, Inc. He previously worked as Chemistry Director at Genaera Corp.
from 1993 to 1999, Principal Scientist at Wyeth Pharmaceuticals LLC from 1984 to 1993, and Chief Scientific Officer at TYG Solutions Corp.
He received his undergraduate degree from The Ohio State University in 1979 and his doctorate degree from the same university in 1984.
Postes actifs de William Kinney
| Sociétés | Poste | Début |
|---|---|---|
| NEUROPATHIX, INC. | Chief Tech/Sci/R&D Officer | 25/07/2018 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Founder | 01/01/2016 |
Kannalife Sciences, Inc.
 Kannalife Sciences, Inc. Pharmaceuticals: MajorHealth Technology Kannalife Sciences, Inc. engages in the provision of biopharmaceutical services. It develops disruptive cannabinoid based therapeutics that design to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis and Dean Petkanas in 2010 and is headquartered in Doylestown, PA. | Chief Tech/Sci/R&D Officer | - |
| Iteramed | Founder | 01/01/2008 |
| Natural Product Discovery Institute | Director/Board Member | - |
Anciens postes connus de William Kinney
| Sociétés | Poste | Fin |
|---|---|---|
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Corporate Officer/Principal | 01/01/1999 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 01/01/1993 |
TYG Solutions Corp.
 TYG Solutions Corp. Pharmaceuticals: MajorHealth Technology TYG Solutions Corp. is a development stage company, which engages in the provision of corporate website design services. It focuses on mobile app development and corporate website design. The company was founded on March 25, 2013 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
Formation de William Kinney
| The Ohio State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Kannalife Sciences, Inc.
Kannalife Sciences, Inc. Pharmaceuticals: MajorHealth Technology Kannalife Sciences, Inc. engages in the provision of biopharmaceutical services. It develops disruptive cannabinoid based therapeutics that design to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis and Dean Petkanas in 2010 and is headquartered in Doylestown, PA. | Health Technology |
TYG Solutions Corp.
TYG Solutions Corp. Pharmaceuticals: MajorHealth Technology TYG Solutions Corp. is a development stage company, which engages in the provision of corporate website design services. It focuses on mobile app development and corporate website design. The company was founded on March 25, 2013 and is headquartered in San Diego, CA. | Health Technology |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
Neuropathix, Inc.
 Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Neuropathix, Inc. is a biopharmaceutical company. It engages in the research and development of novel new therapeutic agents designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis in 2010 and is headquartered in Doylestown, PA. | Health Technology |
| Iteramed | |
| Natural Product Discovery Institute |
